Rare Blood Clotting Disorder after J&J Vaccine: What You Need to Know
Earlier today, the U.S. CDC and FDA jointly recommended a temporary “pause” on use of the Janssen/Johnson & Johnson (J&J) COVID-19 vaccine in the U.S. due to reports of a rare clotting disorder among young women who had recently received the J&J vaccine. The CDC’s Advisory Committee on Immunization Practices will meet tomorrow, April 14 to further review the data on this condition. Read on for what you need to know about this emerging situation.